Galmed Pharmaceuticals: Q1 Earnings Snapshot

May 17, 2022 GMT

TEL AVIV, Israel (AP) _ Galmed Pharmaceuticals Ltd. (GLMD) on Tuesday reported a loss of $6.1 million in its first quarter.

On a per-share basis, the Tel Aviv, Israel-based company said it had a loss of 24 cents.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on GLMD at